The functions of the TGF-β signaling pathway in the GBM subgroups were investigated at the molecular level by western blotting, which allowed analysis of the phosphorylation status of Smad2 and Smad3 in proneural and mesenchymal GBM cells. The gene discussed is SMAD2; the disease is glioblastoma.